Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| peri_operative_medication_management [2026/04/09 03:27] – [Immunosuppressants for transplant] Scott Larson | peri_operative_medication_management [2026/04/09 03:30] (current) – Scott Larson | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ====== Peri-Operative Medication Management ====== | ====== Peri-Operative Medication Management ====== | ||
| - | FIXME | + | |
| ====Cardiovascular and Hypertensive Medication==== | ====Cardiovascular and Hypertensive Medication==== | ||
| * Beta Blockers- continue through surgery | * Beta Blockers- continue through surgery | ||
| Line 175: | Line 175: | ||
| * If patient is on an mTOR inhibitor (sirolimus or everolimus), | * If patient is on an mTOR inhibitor (sirolimus or everolimus), | ||
| - | 11. | + | ====Hematology |
| * Best to discuss IN ADVANCE OF SURGERY with Hematologist and surgeon for guidance during perioperative period. | * Best to discuss IN ADVANCE OF SURGERY with Hematologist and surgeon for guidance during perioperative period. | ||
| * Palbociclib (Ibrance)-- can cause neutropenia, | * Palbociclib (Ibrance)-- can cause neutropenia, | ||